Search

everythinglearnresearchcommunity

for

Search:↓

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Oral contraceptives can effectively treat acne by reducing oil production.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Most women with excessive hair growth have a hormonal cause.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.